Detalhe da pesquisa
1.
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.
Blood Cancer J
; 13(1): 19, 2023 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697388
2.
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".
Cancers (Basel)
; 14(11)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681747